DRI Capital To Pursue Phase III Assets With Some Of Its Third Royalty Fund
This article was originally published in The Pink Sheet Daily
Executive Summary
Toronto-based health care royalty acquirer raises a $1.45 billion third fund, which it says should last between three-and-a-half and five years. It is mainly sticking with its prior investment strategy, although for the first time DRI will look at acquiring royalty rights to promising Phase III candidates.
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: